Metraipolis › archive › dc_8a8a78e64d6e

Monitoring EML4-ALK Biomarkers via a Microfluidic Assay for Treatment Efficacy Assessment — Europe PMC PMID:42783151

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42783151
DOI
10.3390/bios16090484
License (as archived)
solo-consultazione
Archived
2026-10-16T05:19:28.695Z
SHA-256 of the archived text
8255ff24a74c3110d586fa3674a5accad9ea9167c758f0f28893e11677a0fe71
Stable URL of this page
https://metraipolis.com/documento/dc_8a8a78e64d6e

How to cite

Monitoring EML4-ALK Biomarkers via a Microfluidic Assay for Treatment Efficacy Assessment — Europe PMC PMID:42783151 — Europe PMC (en), https://europepmc.org/article/MED/42783151 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a8a78e64d6e (Metraipolis archive dc_8a8a78e64d6e, sha256 8255ff24a74c3110d586fa3674a5accad9ea9167c758f0f28893e11677a0fe71)
BibTeX
@misc{dc8a8a78e64d6e,
  title = {Monitoring EML4-ALK Biomarkers via a Microfluidic Assay for Treatment Efficacy Assessment — Europe PMC PMID:42783151},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42783151},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a8a78e64d6e; sha256 8255ff24a74c3110d586fa3674a5accad9ea9167c758f0f28893e11677a0fe71},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42783151. Agents can read the archived copy with the MCP tool read_document.